India’s pharmaceutical exports have increased by 9.4% to $30.47 billion in FY25, which shows the global strength of the sector. At Chintan Shivir in Ahmedabad, government and industry leaders discussed the strategy to increase exports more rapidly. India today ranks third in the world in terms of production and exports medicines to more than 200 countries. The largest buyer is the United States, which has 34% share, while Europe has 19% share. European Union’s $572 billion pharma market can become a big opportunity for Indian companies. The target is to take the domestic market to $130 billion by 2030. If trade talks and policies remain correct, then double-digit growth is considered certain in the next 2–3 years.
Global journey of Made in India Medicines: 9.4% growth in FY25, now next target 2027. Money Live
